Healthcare - Biotechnology - NASDAQ - IL
$ 3.55
3.5 %
$ 24.2 M
Market Cap
-0.41
P/E
INCOME STATEMENT
0
REVENUE
-22.9 M
OPERATING INCOME
-23.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
PolyPid Ltd.
| Revenue | 0 |
| Cost Of Revenue | 1.82 M |
| Gross Profit | -1.82 M |
| Operating Expenses | 21 M |
| Operating Income | -22.9 M |
| Other Expenses | 998 K |
| Net Income | -23.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||||
| Cost Of Revenue | 1.8 | 1.7 | 1.1 | 1.0 | 0.9 | 0.4 | 0.2 | 0.1 | 0.1 | 0 | 0 |
| Gross Profit | (1.8) | (1.7) | (1.1) | (1.0) | (0.9) | (0.4) | (0.2) | (0.1) | (0.1) | 0 | 0 |
| OPERATING INCOME | |||||||||||
| Operating Expenses | 21.0 | 38.9 | 42.9 | 26.3 | 18.6 | 18.4 | 13.8 | 10.3 | 8.6 | 3.6 | 1.8 |
| Selling, General and Administrative Expenses | 4.9 | 10.9 | 12.5 | 9.3 | 4.5 | 5.8 | 4.1 | 2.6 | 2.9 | 0.9 | 0.4 |
| Research and Development Expenses | 16.1 | 28.0 | 30.4 | 17.0 | 14.1 | 12.6 | 9.7 | 7.7 | 5.6 | 2.6 | 1.4 |
| Operating Income | (22.9) | (38.9) | (42.9) | (26.3) | (18.6) | (18.4) | (13.8) | (10.3) | (11.3) | (3.6) | (1.8) |
| PRE-TAX INCOME | |||||||||||
| Interest Income Expense | 1.7 | 1.0 | 0 | 17 K | 15 K | 42 K | 40.7 | 1.1 | (1.5) | 0 | 0 |
| Total Other Income | (0.9) | (0.5) | 0.5 | (10.6) | 11.7 | 24.3 | (40.7) | (1.1) | (1.2) | (0.3) | 3 K |
| Pre-Tax Income | (23.8) | (39.4) | (42.3) | (36.9) | (6.9) | 5.9 | (54.5) | (11.4) | (9.7) | (3.9) | (1.8) |
| NET INCOME | |||||||||||
| Tax Provision | 69 K | 97 K | (1.6) | (1.5) | (11.7) | (24.3) | 40.7 | 1.1 | (1.5) | 0.3 | 3 K |
| Net Income | (23.9) | (39.5) | (40.7) | (35.3) | 4.8 | 5.9 | (54.5) | (11.4) | (8.2) | (3.9) | (1.8) |
| EPS | 17 | 61 | 65.2 | 111 | 10.7 | 13.3 | 185 | 38.7 | 18.8 | 19.8 | 4.04 |